Showing results (161-170 of 538) with videos related to
Sort By:
Pageof 54
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|March 1, 2008
Imaging and dosimetry of 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumorsHiroaki Kurihara, David J Yang, Massimo Cristofanilli, et al.International Journal of Clinical Oncology|May 25, 2011
Serum HER2 levels determined by two methods in patients with metastatic breast cancerNaoki Hayashi, Seigo Nakamura, Yasuharu Tokuda, et al.Cancer|August 28, 2003
A Phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with metastatic breast carcinomaFrancisco J Esteva, Edgardo Rivera, Massimo Cristofanilli, et al.EMBO Molecular Medicine|November 24, 2020
New insight into the significance of KLF4 PARylation in genome stability, carcinogenesis, and therapyZhuan Zhou, Furong Huang, Indira Shrivastava, et al.Cancer|September 12, 2008
Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?Shaheenah Dawood, Kristine Broglio, Vicente Valero, et al.Cancer|May 27, 2010
Suberoylanilide hydroxamic acid blocks self-renewal and homotypic aggregation of inflammatory breast cancer spheroidsFredika M Robertson, Wendy A Woodward, Ross Pickei, et al.Minerva Medica|April 28, 2020
The generally low sensitivity of CA 125 for FIGO stage I ovarian cancer diagnosis increases for endometrioid histotypeGiovanni Grandi, Anna M Perrone, Angela Toss, et al.Minerva Obstetrics and Gynecology|May 14, 2021
Carboplatin-paclitaxel in triple-negative metastatic breast cancer during pregnancy with neoplastic thrombosisFrancesca Monari, Giovanni Grandi, Isotta Guidotti, et al.Cancer|April 22, 2003
Nipple aspirate fluid cytology in breast carcinomaSavitri Krishnamurthy, Nour Sneige, Patricia A Thompson, et al.BMC Cancer|May 15, 2020
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trialsClaudia Omarini, Federico Piacentini, Isabella Sperduti, et al.Pageof 54